Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guozhen Maca tablet is a botanical dietary supplement and nutraceutical product marketed under the Guozhen brand, which is owned by New Era Health Industry (Group) Co., Ltd. The product contains extracts from Maca (*Lepidium meyenii*), a plant native to the high Andes of Peru known for its adaptogenic properties. In the context of Traditional Chinese Medicine (TCM), it is utilized to address kidney essence deficiency syndrome, a condition often associated with aging, fatigue, and diminished vitality. The product is currently being evaluated in clinical research, including Phase 0 randomized, placebo-controlled trials conducted by the Beijing University of Chinese Medicine, to assess its safety and anti-aging effectiveness in older adults.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Guozhen Maca tablet.